VNF-24105-79822
3 vaccinations
4 coded responses
45 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 452 / OH
- Registered
- 2021-03-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-07
Registered in v-safe
-
2021-03-07
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-07
-
2021-03-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-03-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-21
- 2021-03-28
- 2021-04-04
- 2021-04-11
- 2021-04-18
- 2021-06-06
- 2021-09-05
-
2021-11-01
Dose 2 — Pfizer-BioNTechCo-administered: Flu
- 2021-11-01
-
2021-11-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-11-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-11-04
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-16
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2021-12-13
-
2022-01-31
Survey response — 3 months, dose 2MedDRA: Cough, Headache, Nasopharyngitis, Respiratory tract congestion — Feeling: GoodFree text: Moderate cold-like symptoms - congestion, headache, cough. Resolved after about 2 weeks.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-02
- 2022-11-01
-
2022-11-07
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-11-08
Survey response — days 1–6 daily, dose 3MedDRA: Cough — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: CoughMedDRA releases: 2024-11 · check-in free text available
- 2022-11-09
- 2022-11-10
- 2022-11-11
- 2022-11-12
- 2022-11-13
- 2022-11-14
-
2022-11-21
Survey response — day 14, dose 3MedDRA: Diarrhoea, Dizziness, Fatigue, Nausea, Pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fatigue, nausea, diarrhea, light-headedness, full-body aches. Onset 11 days after vaccinationMedDRA releases: 2024-11 · check-in free text available
- 2022-11-28
-
2022-12-05
Survey response — day 28, dose 3MedDRA: Cough, Pain, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cough, congestion, achesMedDRA releases: 2024-11 · check-in free text available
- 2022-12-12
- 2022-12-21
- 2023-02-06
- 2023-05-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-07 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-01 | Pfizer-BioNTech | Flu |
| 3 | 2022-11-07 | Pfizer-BioNTech | Flu |
Free text
Release 11 — 3 months, dose 2
Symptoms: Moderate cold-like symptoms - congestion, headache, cough. Resolved after about 2 weeks.
Release 12 — days 1–6 daily, dose 3
Systemic reaction (other): Cough
Release 12 — day 14, dose 3
Symptoms: Fatigue, nausea, diarrhea, light-headedness, full-body aches. Onset 11 days after vaccination
Release 12 — day 28, dose 3
Symptoms: Cough, congestion, aches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release